UA84031U - Method for use of dry citrate rabbit plasma for demonstration of reaction of precipitation - Google Patents

Method for use of dry citrate rabbit plasma for demonstration of reaction of precipitation

Info

Publication number
UA84031U
UA84031U UAU201303996U UAU201303996U UA84031U UA 84031 U UA84031 U UA 84031U UA U201303996 U UAU201303996 U UA U201303996U UA U201303996 U UAU201303996 U UA U201303996U UA 84031 U UA84031 U UA 84031U
Authority
UA
Ukraine
Prior art keywords
demonstration
precipitation
reaction
rabbit plasma
citrate
Prior art date
Application number
UAU201303996U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Александра Олеговна Вовк
Марина Юрьевна Перфильева
Игорь Славович Гайдаш
Original Assignee
Александра Олеговна Вовк
Марина Юрьевна Перфильева
Игорь Славович Гайдаш
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Александра Олеговна Вовк, Марина Юрьевна Перфильева, Игорь Славович Гайдаш filed Critical Александра Олеговна Вовк
Priority to UAU201303996U priority Critical patent/UA84031U/en
Publication of UA84031U publication Critical patent/UA84031U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A method for demonstration of precipitation reaction includes use of 15% solution of nitric acid (as immune serum) and antigen-extract. Dry citrate rabbit plasma is used as antigen-extract, one ampoule of that is diluted with 15 ml of 0.9 % solution of sodium chloride.
UAU201303996U 2013-04-01 2013-04-01 Method for use of dry citrate rabbit plasma for demonstration of reaction of precipitation UA84031U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201303996U UA84031U (en) 2013-04-01 2013-04-01 Method for use of dry citrate rabbit plasma for demonstration of reaction of precipitation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201303996U UA84031U (en) 2013-04-01 2013-04-01 Method for use of dry citrate rabbit plasma for demonstration of reaction of precipitation

Publications (1)

Publication Number Publication Date
UA84031U true UA84031U (en) 2013-10-10

Family

ID=52283389

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201303996U UA84031U (en) 2013-04-01 2013-04-01 Method for use of dry citrate rabbit plasma for demonstration of reaction of precipitation

Country Status (1)

Country Link
UA (1) UA84031U (en)

Similar Documents

Publication Publication Date Title
PH12020551397A1 (en) Cot modulators and methods of use thereof
PH12017500838A1 (en) Solution comprising nicotine in unprotonated form and protonated form
CL2015003738A1 (en) Stable liquid formulation of amg-416 (velcalcetide)
NZ738538A (en) 6-amino-quinoline-3-carbonitrils as cot modulators
MX2022011225A (en) Pharmaceutical formulations of a hif hydroxylase inhibitor.
TR201909447T4 (en) Aramkol salts.
PH12016500720A1 (en) Stable formulation of insulin glulisine
MX2015016676A (en) Stable oral solutions for combined api.
TWD167749S (en) electrical connector
EA201690036A1 (en) COMPOSITION WITH EXTENDED GRIPPING, CONTAINING CYTEHAMINE GRANULES AND METHODS FOR ITS PREPARATION AND APPLICATION
MX2015006407A (en) Method for the preparation of human albumin with reduced level of dissolved oxygen.
BR112015028252A2 (en) Lung cancer treatment method by muc-1 lipopeptide vaccination
UA84031U (en) Method for use of dry citrate rabbit plasma for demonstration of reaction of precipitation
TWD167748S (en) electrical connector
PL414738A1 (en) Method for obtaining submicrocrystalline yttrium-potassium fluoride KY3F10
MX2016005220A (en) Acid dyes, process for the production thereof and their use.
MX2016005222A (en) Acid dyes, process for the production thereof and their use.
PE20171536A1 (en) RECOVERY METHOD FOR TANANE MINERAL
EA201591644A1 (en) DOSAGE FORM CONTAINING CRYZOTINIB
IN2014DN01814A (en)
GB201201411D0 (en) Antiviral article
TWD177185S (en) electrical connector
TWD177184S (en) electrical connector
MX2016005221A (en) Acid dyes, process for their production and their use.
PL403105A1 (en) Amphotericin B complex, a method for preparing a complex of amphotericin B and amphotericin B. Use of a preparation of the medicament